SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011122
Filing Date
2021-08-10
Accepted
2021-08-10 16:02:41
Documents
50
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrns-20210630x10q.htm   iXBRL 10-Q 1628175
2 EX-31.1 mrns-20210630xex31d1.htm EX-31.1 13598
3 EX-31.2 mrns-20210630xex31d2.htm EX-31.2 13754
4 EX-32.1 mrns-20210630xex32d1.htm EX-32.1 7704
5 GRAPHIC mrns-20210630x10q004.jpg GRAPHIC 33343
6 GRAPHIC mrns-20210630x10q007.jpg GRAPHIC 55098
  Complete submission text file 0001558370-21-011122.txt   5198279

Data Files

Seq Description Document Type Size
7 EX-101.SCH mrns-20210630.xsd EX-101.SCH 37575
8 EX-101.CAL mrns-20210630_cal.xml EX-101.CAL 43408
9 EX-101.DEF mrns-20210630_def.xml EX-101.DEF 118157
10 EX-101.LAB mrns-20210630_lab.xml EX-101.LAB 349712
11 EX-101.PRE mrns-20210630_pre.xml EX-101.PRE 228924
12 EXTRACTED XBRL INSTANCE DOCUMENT mrns-20210630x10q_htm.xml XML 614598
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 211159827
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences